I am very honoured to be the new President of the European Society of Pathology (ESP). I was nominated as President – elected two years ago – and have witnessed many evolutionary changes in our Society. These changes have been possible due to the great achievements of the previous Executive Committee, the Council, the Education Subcommittee, the Advisory Board, the Working Groups and other committees under the leadership of Professor Dina Tiniakos. The 2019 ESP Strategy Meeting in Athens was organised to develop a new vision and mission for our Society. The recommendations of the ESP Strategy Meeting are now approved by the Council and will be implemented in the next five years. The transformation of the ESP will be associated with the new vision: Excellence in pathology for optimal patient care. Our mission is to promote high quality pathology diagnosis for all patients, to promote up-to-date education across Europe and to support cutting-edge research to understand disease and translate science into clinical practice. It is acknowledged that ESP plays an important role to provide cutting-edge information using digital pathology as well as traditional platforms. These tools and the annual Congress of the European Society will strengthen the ESP educational and scientific offerings to the ESP members.
The 2019 ESP Congress in Nice, France, chaired by Prof. Dina Tiniakos and Prof. Paul Hofman was well-prepared by the organisers and was a great success, both in terms of attendance, level of discussions, and inspirational mentoring. It was impressive to see the digital transformation of our discipline. The 2020 ESP meeting in Glasgow is currently prepared together with the British Division of the IAP. The process to select cities to host ECPs in 2024 and 2025 has already started.
ESP Academy in 2020
A call for applications will be sent out to all members interested in applying for this interactive workshop.
I am looking forward to the next two years as President of the European Society of Pathology and will work hard to further develop our Society, to strengthen existing collaborations and develop new partnerships with medical and scientific societies.